More Healthcare Coverage
-
January 16, 2026
Immigrant Visa Pause Could Test Limits Of Executive Power
The Trump administration's indefinite pause on immigrant visas for applicants from 75 countries may test the outer bounds of executive control over visa issuance and prompt court battles in a rarely litigated area of immigration law.
-
January 16, 2026
Walgreens Workers Snag $2.5M Deal To End Late Pay Suit
Walgreens has agreed to pay $2.5 million to a class of workers who accused the pharmacy chain of not paying their final paychecks on time, the workers said Friday, urging an Oregon federal court to greenlight the settlement.
-
January 16, 2026
Supreme Court Takes On Hikma's 'Skinny Label' Patent Case
The U.S. Supreme Court agreed Friday to hear Hikma Pharmaceuticals Inc.'s appeal of a decision reviving a patent case over its "skinny label" on a generic heart drug, after the Trump administration urged the court to take the case.
-
January 15, 2026
Trial 'No Longer Warranted' After Judge's Stelara Reversal
The fate of insurer CareFirst's suit accusing Johnson & Johnson of using a merger and patent fraud to anticompetitively protect immunosuppressive drug Stelara from competition is in doubt after a Virginia federal judge reversed course and nixed key claims he had previously teed up for trial.
-
January 15, 2026
State Dept. Releases List Of Countries Targeted By Visa Pause
The U.S. Department of State released an official list of the 75 countries for which it will pause issuing immigrant visas, after it said immigrants from these countries "take welfare from the American people at unacceptable rates."
-
January 14, 2026
State Dept. Pauses Immigrant Visas For 75 Countries
The U.S. Department of State said Wednesday that it is indefinitely pausing immigrant visas for people from 75 countries who the agency said are likely to rely on government support and stress the public purse.
-
January 12, 2026
CareFirst Opposes J&J's Bid To Revisit Stelara Antitrust Case
Insurer CareFirst urged a Virginia federal court to reject Johnson & Johnson's bid for reconsideration of a ruling that refused to toss antitrust and patent fraud claims over the immunosuppressive drug Stelara.
-
January 12, 2026
7th Circ. Finds DEA, State Officials Immune In Pill Mill 'Mess'
The Seventh Circuit Monday overturned rulings that would have let a doctor's Fourth and Fifth amendments claims over a pill mill investigation go to trial, concluding federal and state officials are entitled to immunity in proceedings the court described as a "tangled mess."
-
January 12, 2026
Terumo Plaintiff Settles, Drops Cancer Case Before Trial
One of the two plaintiffs set to take their case to trial this month against Terumo BCT Inc. accusing the company of causing their cancer reached a stipulation to dismiss his case with prejudice Friday, according to court records.
-
January 12, 2026
7th Circ. Won't Rehear Psychiatrists' Antitrust Suit Revival Bid
The Seventh Circuit is standing firm on a panel majority's refusal to revive an antitrust suit challenging the American Board of Psychiatry and Neurology's certification maintenance requirement, having refused to rehear appellate arguments over a lower court decision tossing the case.
-
January 12, 2026
Elevance Nurses Are Owed No OT, Judge Told As Trial Opens
Elevance Health Inc. said Monday that claims it violated labor law by denying overtime pay to registered nurses evaluating insurance claims are "preposterous," as a Georgia federal bench trial kicked off over a suit from nearly 40 nurses alleging they were stiffed on years of pay.
-
January 12, 2026
Justices Won't Weigh Collective Cert. Process In Eli Lilly Case
The U.S. Supreme Court declined on Monday to review whether courts should stick with a long-standing two-step analysis for certifying collective actions in an age discrimination case against Eli Lilly and Co. that could have affected wage and hour litigation.
-
January 09, 2026
$500K Revelation Doesn't Nix Surgeon's Win In Eye Injury Row
A California appeals court won't order a retrial in a suit alleging a surgery center blinded a patient in one eye during spinal surgery, saying she failed to properly object to a closing argument that implied that a co-defendant's settlement was the source of $500,000 she had received.
-
January 09, 2026
Judge Denies 'Fatally Untimely' Bid For New Poaching Trial
A Boston federal judge has denied what she called a "fatally untimely" motion for a new trial after a jury handed Cynosure LLC a $25 million verdict against two former employees who the company said caused other employees to breach their noncompete and nonsolicitation agreements.
-
January 09, 2026
How NY Atty Helped Win 12-Year Fight Over Hospital Pricing
When Matthew Cantor got involved in a sweeping antitrust case against California-based healthcare network Sutter Health, his youngest son was in the first grade. By the time the case settled in the fall, he was a sophomore in college. Here’s the story of how Cantor and his team kept fighting for more than a decade.
-
January 06, 2026
Ramey Blocked As Atty In Image Patent Fight In NY
Intellectual property attorney William Ramey was prevented from representing the owner of image processing and modifying patents used in special eyeglasses in an infringement suit in New York federal court, leading the company to abandon the case.
-
January 06, 2026
3rd Circ. Backs DOL In Home Healthcare Wage Case
The Third Circuit upheld a $1 million judgment against home health company WiCare Home Care Agency LLC Tuesday, finding it was within the secretary of labor's power to write regulations keeping "third-party employers" subject to the Fair Labor Standards Act and not exempt under a provision for "companionship services."
-
January 06, 2026
Fla. Court Won't Rehear Reversal Of $213M 'Maya' Award
A Florida appeals court said Monday it will not reconsider its decision that reversed a $213 million judgment against a Florida hospital in favor of Maya Kowalski, the subject of the Netflix documentary "Take Care of Maya."
-
January 05, 2026
Fed. Circ. Examines Timing Of $452M Trade Secrets Suit
A Federal Circuit panel delved into the statute of limitations for trade secrets cases Monday, pressing an attorney for a South Korean company seeking to reverse a verdict that prompted a $452 million jury award to explain why the clock should start when a plaintiff suspects misappropriation rather than when it is actually discovered.
-
December 23, 2025
Justices Urged To Spurn SG's Call To Tackle 'Skinny Labels'
Amarin Pharma Inc. on Tuesday urged the U.S. Supreme Court to reject the U.S. solicitor general's call to hear a patent case involving generic drug "skinny labels," saying the dispute over the company's heart drug Vascepa deals with factual issues not suitable for high court review.
-
December 23, 2025
7th Circ. Revives Sales Reps' Pay Bias Suit Against Waste Co.
The Seventh Circuit reinstated a pay bias suit Tuesday from two medical waste sales representatives who claimed their male colleagues unfairly received higher base salaries, finding they cast doubt on the company's sex-neutral justifications for the disparity.
-
December 22, 2025
6th Circ. Vacates Pharma Salesman's $6.8M Restitution Order
The Sixth Circuit vacated a nearly $7 million restitution order against a pharmaceutical salesman convicted of healthcare fraud, finding an Ohio federal court erred in calculating that amount and apportioning liability.
-
December 19, 2025
Feds Fight 'Do-Over' Of Tort Atty's Attempted-Extortion Rap
Federal prosecutors are urging the Fourth Circuit not to give "a do-over" to a medical malpractice attorney who was convicted of attempting to extort the University of Maryland Medical System out of $25 million and who says his self-representation at trial was not competent.
-
December 19, 2025
Squires Issues 21 More Patent Review Denials
U.S. Patent and Trademark Office Director John Squires has denied 21 requests for America Invents Act patent reviews, while not agreeing to institute any new proceedings.
-
December 19, 2025
Hospital Knocks Discharge Claim From EEOC Sex Bias Suit
An Arkansas federal judge agreed to cut the constructive discharge allegation from a U.S. Equal Employment Opportunity Commission lawsuit alleging two doctors at an Arkansas hospital refused to let a male medical assistant help with childbirth, noting that the worker assisted with other deliveries.
Expert Analysis
-
4 Ways GCs Can Manage Growing Service Of Process Volume
As automation and arbitration increase the volume of legal filings, in-house counsel must build scalable service of process systems that strengthen corporate governance and manage risk in real time, says Paul Mathews at Corporation Service Co.
-
The Law Firm Merger Diaries: Forming Measurable Ties
Relationship-building should begin as early as possible in a law firm merger, as intentional pathways to bringing people together drive collaboration, positive client response, engagements and growth, says Amie Colby at Troutman.
-
US Cybersecurity Strategy Must Include Immigration Reform
Cyberthreats are escalating while the cybersecurity workforce remains constrained due to a lack of clear standards for national-interest determinations, processing backlogs affecting professionals who protect critical public systems and visa allocations that do not reflect real-world demands, says Rusten Hurd at Colombo & Hurd.
-
Judges On AI: How Courts Can Boost Access To Justice
Arizona Court of Appeals Judge Samuel A. Thumma writes that generative artificial intelligence tools offer a profound opportunity to enhance access to justice and engender public confidence in courts’ use of technology, and judges can seize this opportunity in five key ways.
-
DHS' Parole Termination Violates APA And Due Process
The U.S. Department of Homeland Security’s abrupt termination of family reunification parole programs violates both the Administrative Procedure Act and the due process rights of vetted beneficiaries who relied on the government's explicit invitation to wait in the U.S. for an immigrant visa to become available, says Abdoul Konare at Konare Law.
-
2025's Most Notable State AG Activity By The Numbers
State attorneys general were active in 2025, working across party lines to address federal regulatory gaps in artificial intelligence, take action on consumer protection issues, continue antitrust enforcement and announce large settlements on behalf of their citizens, say attorneys at Jenner & Block.
-
The Case For Emulating, Not Dividing, The Ninth Circuit
Champions for improved judicial administration should reject the unfounded criticisms driving recent Senate proposals to divide the Ninth Circuit and instead seek to replicate the court's unique strengths and successes, says Ninth Circuit Judge J. Clifford Wallace.
-
How 11th Circ.'s Zafirov Decision Could Upend Qui Tam Cases
Oral argument before the Eleventh Circuit last month in U.S. ex rel. Zafirov v. Florida Medical Associates suggests that the court may affirm a lower court's opinion that the qui tam provisions of the False Claims Act are unconstitutional — which could wreak havoc on pending and future qui tam cases, say attorneys at Morgan Lewis.
-
Law School's Missed Lessons: Intentional Career-Building
A successful legal career is built through intention: understanding expectations, assessing strengths honestly and proactively seeking opportunities to grow and cultivating relationships that support your development, say Erika Drous and Hillary Mann at Morrison Foerster.
-
Employment Immigration Trends And Challenges For 2026
U.S. companies competing for global talent should brace for a turbulent 2026, with greater compliance burdens, higher costs and the probability of workforce disruptions at every stage of the immigration process, from visa petitions to work authorization renewals, say attorneys at Duane Morris.
-
Top 5 Antitrust Issues For In-House Counsel To Watch In 2026
With Trump administration enforcement policy having largely taken shape last year, antitrust issues that in-house counsel should have on the radar range from scrutiny of technology-assisted pricing to the return of merger remedies, say attorneys at Squire Patton.
-
4 Developments That Defined The 2025 Ethics Landscape
The legal profession spent 2025 at the edge of its ethical comfort zone as courts, firms and regulators confronted how fast-moving technologies and new business models collide with long-standing professional duties, signaling that the profession is entering a period of sustained disruption that will continue into 2026, says Hilary Gerzhoy at HWG Law.
-
How Fractional GCs Can Manage Risks Of Engagement
As more organizations eliminate their in-house legal departments in favor of outsourcing legal work, fractional general counsel roles offer practitioners an engaging and flexible way to practice at a high level, but they can also present legal, ethical and operational risks that must be proactively managed, say attorneys at Boies Schiller.